Hansen, A. R., Zhang, A. Y., Boni, V., Mantia, C., Yu, E. Y., Weickhardt, A. J., Robert, M., Gupta, S., Morales-Barrera, R., Hoimes, C. J., Berlin, J., Iyer, G., Millward, M., Lihou, C. F., Loriot, Y., Pouessel, D., Mittal, K., Hill, A. G., Racca, F., Tran, B. (2025). A multicenter, open-label phase 1/2 study of TYRA-300 in advanced urothelial carcinoma and other solid tumors with activating FGFR3 alterations (SURF301).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps904